Redox and Kno2 Collaborate to Revolutionize Healthcare Data Exchange Across The U.S.

Strategic Alliance Between Redox and Kno2

In a significant development for the healthcare sector, Redox and Kno2 have joined forces to improve healthcare data exchange across the nation. This strategic alliance addresses the persistent issues surrounding interoperability in healthcare, aiming to provide seamless access and usability of clinical data.

A Unified Approach to Interoperability

Redox, a frontrunner in healthcare interoperability, boasts a flexible data exchange platform that operates in real-time. Meanwhile, Kno2 excels at managing healthcare communications and has been officially recognized as a Qualified Health Information Network (QHIN). Together, these two companies facilitate over 40 billion transactions annually, linking nearly 160,000 provider organizations, which means that about 75% of health systems and 80% of non-acute provider settings benefit from this collaboration.

With this alliance, they promise to create a comprehensive solution for securely connecting and transforming clinical data, making it usable across various Electronic Health Record (EHR) systems and provider networks nationwide.

Addressing Critical Healthcare Needs

The partnership is designed to resolve both sides of the interoperability equation. Kno2 is proficient in moving data efficiently across diverse channels, such as fax and Fast Healthcare Interoperability Resources (FHIR), while Redox provides an established network and infrastructure to convert that data into actionable insights.

Key Features of the Alliance:

1. Unified Integration: A single connection point that offers access to the extensive combined network.
2. Scalable Architecture: Compatibility extends from small EHRs to large enterprise health systems and payers, facilitating bi-directional data flow.
3. Universal Data Translation: The technology can scale and normalize data formats like HL7v2, FHIR, X12, CDA, and proprietary formats, ensuring compatibility across all systems.
4. Nationwide TEPCA Connectivity: Leveraging Kno2's QHIN status gives users integrated access to federal health networks, directly through the Redox platform.

Impact on Healthcare

The United States has faced ongoing challenges concerning the interoperability of healthcare systems, impacted by fragmented data and incompatible systems. This collaboration is timely as the industry looks to comply with increasing federal interoperability requirements while addressing the varied connectivity needs of different stakeholders.

According to Trip Hofer, CEO of Redox, this partnership effectively closes the existing gaps for technology platforms, providers, and payers by allowing teams to connect once and access the entire ecosystem, rather than developing numerous custom integrations.

With billions of clinical documents handled through existing national frameworks, the need for direct system connections remains critical. The Redox and Kno2 partnership aims to deliver significant enhancements in healthcare connectivity, ultimately benefiting providers, patients, and insurers alike.

Conclusion

Existing customers of Redox and Kno2 can begin to access this innovative integrated solution through their respective teams immediately. New clients will be able to utilize this offering starting in early 2026. This partnership is set to reshape the landscape of healthcare data exchange, paving the way for a more connected and efficient healthcare ecosystem.

"A comprehensive and unified approach to healthcare data interoperability is essential as we move forward, and this partnership exemplifies that ideal," says Therasa Bell, President and Co-Founder of Kno2.

With this significant advancement, both companies are poised to transform the healthcare journey, ensuring that patient information is seamlessly and securely shared across the broad spectrum of healthcare providers and systems.